If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,184.00
Bid: 3,192.00
Ask: 3,194.00
Change: 10.00 (0.32%)
Spread: 2.00 (0.063%)
Open: 3,178.00
High: 3,198.00
Low: 3,178.00
Prev. Close: 3,174.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Admission Particulars

20 Nov 2023 18:30

RNS Number : 0507U
Bunzl PLC
20 November 2023

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

20 November 2023

BUNZL FINANCE PLC

ANNUAL UPDATE OF EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

Bunzl Finance plc, a wholly-owned finance subsidiary of Bunzl plc, today announces the annual renewal of its Euro Medium Term Note Programme (the "Programme").

As part of the annual renewal of the Programme, the following admission particulars (the "Admission Particulars") have been submitted and approved by the London Stock Exchange's International Securities Market:

Admission Particulars dated 20 November 2023 relating to the £1,500,000,000 Euro Medium Term Note Programme, issued by Bunzl Finance plc, as Issuer, and unconditionally and irrevocably guaranteed by Bunzl plc, as Guarantor.

A copy of the Admission Particulars can be viewed on Bunzl plc's website at https://www.bunzl.com/investors/shareholder-information/debt-information/

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

For further information, please contact:

Bunzl Finance plc

York House,

45 Seymour Street

London

W1H 7JT

United Kingdom

Email: suzanne.jefferies@bunzl.com

Attention: Suzanne Jefferies

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DOCBIBDBIBDDGXG
Date   Source Headline
3rd Jan 20197:00 amRNSTotal Voting Rights
13th Dec 20187:00 amRNSTrading Statement
6th Dec 201810:00 amRNSDirector/PDMR Shareholding
6th Dec 20187:00 amRNSDirectorate Change
4th Dec 20184:15 pmRNSDirector/PDMR Shareholding
4th Dec 201812:15 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
28th Nov 20184:50 pmRNSDirector/PDMR Shareholding
26th Nov 20188:00 amRNSAdditional Listing
9th Nov 20185:52 pmRNSHolding(s) in Company
2nd Nov 20183:00 pmRNSDirector/PDMR Shareholding
1st Nov 201812:29 pmRNSBlock listing Interim Review
24th Oct 20183:30 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSTrading Statement
16th Oct 20187:00 amRNSHolding(s) in Company
10th Oct 20185:36 pmRNSDirector/PDMR Shareholding
5th Oct 20183:15 pmRNSDirector/PDMR Shareholding
2nd Oct 20185:15 pmRNSDirector/PDMR Shareholding
1st Oct 201810:30 amRNSTotal Voting Rights
27th Sep 201811:27 amRNSDirector/PDMR Shareholding
4th Sep 20185:00 pmRNSDirector/PDMR Shareholding
4th Sep 20189:50 amRNSTotal Voting Rights
3rd Sep 20185:15 pmRNSDirector/PDMR Shareholding
29th Aug 20185:12 pmRNSDirector/PDMR Shareholding
29th Aug 20185:11 pmRNSDirector/PDMR Shareholding
29th Aug 20185:09 pmRNSDirector/PDMR Shareholding
28th Aug 20184:35 pmRNSDividend Declaration
28th Aug 20187:00 amRNSHalf-year Report
28th Aug 20187:00 amRNSAcquisition
1st Aug 20184:30 pmRNSTotal Voting Rights
13th Jul 201810:30 amRNSDirector/PDMR Shareholding
2nd Jul 201812:30 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 201810:45 amRNSTotal Voting Rights
24th May 201812:30 pmRNSDirector/PDMR Shareholding
23rd May 20183:30 pmRNSDirector/PDMR Shareholding
23rd May 20181:00 pmRNSDirector/PDMR Shareholding
23rd May 201810:51 amRNSDirector Declaration
18th May 20188:00 amRNSAdditional Listing
10th May 20188:12 amRNSDirector/PDMR Shareholding
9th May 201812:00 pmRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSHolding(s) in Company
2nd May 201810:40 amRNSBlock listing Interim Review
2nd May 201810:30 amRNSDirector/PDMR Shareholding
2nd May 201810:08 amRNSTotal Voting Rights
30th Apr 201810:04 amRNSHolding(s) in Company
23rd Apr 20181:31 pmRNSDirector Declaration
19th Apr 20183:45 pmRNSDirector/PDMR Shareholding
18th Apr 20183:49 pmRNSResult of AGM
18th Apr 20187:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.